{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:57:10Z","timestamp":1761580630661,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.3816\/cgc.2007.n.025","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:11:35Z","timestamp":1221081095000},"page":"403-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Persistent Hypocalcemia Induced by Zoledronic Acid in a Patient with Androgen-Independent Prostate Cancer and Extensive Bone Metastases"],"prefix":"10.3816","volume":"5","author":[{"given":"James L.","family":"Gulley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Arlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Dahut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CGC.2007.n.025_bib1","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CGC.2007.n.025_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"10.3816\/CGC.2007.n.025_bib3","first-page":"S23","article-title":"Bisphosphonates\u2014history and experimental basis","volume":"8","author":"Fleisch","year":"1987","journal-title":"Bone"},{"key":"10.3816\/CGC.2007.n.025_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdj105","article-title":"Management of the adverse effects associated with intravenous bisphosphonates","volume":"17","author":"Tanvetyanon","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CGC.2007.n.025_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJM200304103481521","article-title":"Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency","volume":"348","author":"Rosen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3816\/CGC.2007.n.025_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1200\/JCO.2004.99.013","article-title":"Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency","volume":"22","author":"Breen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2007.n.025_bib7","first-page":"34","article-title":"Severe hypocalcemia associated with extensive osteoblastic metastases in a patient with prostate cancer","volume":"63","author":"Fokkema","year":"2005","journal-title":"Neth J Med"},{"key":"10.3816\/CGC.2007.n.025_bib8","first-page":"83","article-title":"Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases","volume":"98","author":"Patel","year":"2005","journal-title":"Tenn Med"},{"key":"10.3816\/CGC.2007.n.025_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4158\/EP.11.4.254","article-title":"Hypocalcemia and parathyroid function in metastatic prostate cancer","volume":"11","author":"Tandon","year":"2005","journal-title":"Endocr Pract"},{"key":"10.3816\/CGC.2007.n.025_bib10","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2007.n.025_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.ajkd.2003.08.023","article-title":"Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism","volume":"42","author":"Lu","year":"2003","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311701112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311701112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:21:16Z","timestamp":1761564076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767311701112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1558767311701112"],"URL":"https:\/\/doi.org\/10.3816\/cgc.2007.n.025","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent Hypocalcemia Induced by Zoledronic Acid in a Patient with Androgen-Independent Prostate Cancer and Extensive Bone Metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CGC.2007.n.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}